2014-06-10 19:07:00 UTC

Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis

June 12, 2014

Manish Kumar Lunia and colleagues report in Clinical Gastroenterology and Hepatology that, based on a prospective, randomized controlled trial, probiotics were found to be effective in preventing hepatic encephalopathy in patients with cirrhosis.

Hepatic encephalopathy (HE) is associated with a poor prognosis in patients with advanced liver disease. Probiotics alter the intestinal microbiota with non–urease-producing organisms that reduce production of ammonia. Manish Kumar Lunia and colleagues investigated the efficacy of probiotics for the primary prophylaxis of HE. They report in Clinical Gastroenterology and Hepatology that, based on a prospective, randomized controlled trial, probiotics were found to be effective in preventing HE in patients with cirrhosis.

Clinical Gastroenterology and Hepatology 2014: 12(6): 1003-1008.e1

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Oct. 1, 2017

Among HCV-infected patients treated with DAAs, SVR is associated with a considerable reduction in the risk of HCC; however, the risk for HCC remained high in patients with cirrhosis at the time of SVR.